Target intelligence / Profile preview

Cyclin T2 pseudogene 1 (CCNT2P1)

Target
CCNT2P1
Molecular classification
Other
01

Overview

Cyclin T2 pseudogene 1 (CCNT2P1) refers to a pseudogene related to the functional gene Cyclin T2 (CCNT2). Pseudogenes are nonfunctional copies or segments of genes that do not produce functional protein products. CCNT2P1 is not a protein-coding gene, nor is it known to have biological activity, therapeutic relevance, or direct disease involvement. The functional Cyclin T2 gene (CCNT2) encodes a regulatory subunit of the CDK9/cyclin T complex, important in transcriptional elongation, cell cycle, and development, but pseudogenes like CCNT2P1 lack this protein function[1][2][3][6]. Context and interpretation: "CCNT2P1" is not a canonical therapeutic target but a pseudogene related to Cyclin T2. Pseudogenes are not used as drug targets and have no known disease associations or molecular functions. All structured biological and pharmacological information (e.g., drug interactions, mechanisms, biomarkers) is inapplicable to CCNT2P1. If the intent is to inquire about the functional protein Cyclin T2 (CCNT2), information should be gathered for "Cyclin T2" instead, which is a true protein-coding gene with established molecular and biological roles[1][2][3][6].

Other names
CCNT2 pseudogene 1

Beyond the preview

Go deeper on Cyclin T2 pseudogene 1 (CCNT2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclin T2 pseudogene 1 (CCNT2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call